These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 533399)

  • 61. A 1978 perspective of hemoperfusion.
    Chang TM
    Artif Organs; 1978 Nov; 2(4):359-62. PubMed ID: 743005
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A bioartificial liver used as a bridge to liver transplantation in a 10-year-old boy.
    LePage EB; Rozga J; Rosenthal P; Watanabe F; Scott HC; Talke AM; Demetriou AA
    Am J Crit Care; 1994 May; 3(3):224-7. PubMed ID: 8038852
    [No Abstract]   [Full Text] [Related]  

  • 63. Artificial organs in acute poisoning: to treat or not to treat with artificial organs.
    Knepshield JH; Winchester JF; Maher JF; Garella S; Gibson TP; Seyffart G; Uldall PR
    Trans Am Soc Artif Intern Organs; 1982; 28():666-77. PubMed ID: 7164321
    [No Abstract]   [Full Text] [Related]  

  • 64. Charcoal hemoperfusion. Plus ça change, plus c'est la même chose.
    Berk PD; Goldberg JD
    Gastroenterology; 1988 May; 94(5 Pt 1):1228-30. PubMed ID: 3350293
    [No Abstract]   [Full Text] [Related]  

  • 65. [Substantiation of complex intensive treatment of hepatic failure, complicated by encephalopathy].
    Ivachevsky MM; Ivachevska VV
    Wiad Lek; 2018; 71(2 pt 1):361-365. PubMed ID: 29729174
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Albumin dialysis and plasma filtration adsorption dialysis system.
    Nalesso F; Brendolan A; Crepaldi C; Cruz D; de Cal M; Bellomo R; Ronco C
    Contrib Nephrol; 2007; 156():411-8. PubMed ID: 17464152
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hemodialysis membranes: interleukins, biocompatibility, and middle molecules.
    Hörl WH
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S62-71. PubMed ID: 11792764
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The artificial liver - 1978.
    Winchester JF; Gelfand MC
    Int J Artif Organs; 1979 Jan; 2(1):3-6. PubMed ID: 500238
    [No Abstract]   [Full Text] [Related]  

  • 69. [The role of dialysis membranes in elimination of uremic toxins].
    Grzeszczak W; Zukowska-Szczechowska E; Rutkowski B
    Przegl Lek; 1996; 53(5):439-42. PubMed ID: 8754410
    [No Abstract]   [Full Text] [Related]  

  • 70. Liver support systems: a 1978 perspective.
    Kulbe KD
    Artif Organs; 1979 May; 3(2):143-6. PubMed ID: 119524
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Renal replacement therapy in special settings: extracorporeal support devices in liver failure.
    Cerdá J; Tolwani A; Gibney N; Tiranathanagul K
    Semin Dial; 2011; 24(2):197-202. PubMed ID: 21517988
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Artificial liver: the effect of ACAC microencapsulated charcoal hemoperfusion on fulminant hepatic failure.
    Chirito E; Reiter B; Lister C; Chang TM
    Artif Organs; 1977 Aug; 1(1):76-83. PubMed ID: 616275
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Hb virus induced fulminant hepatitis in hemophilia b--successful management with plasmapheresis and hemoperfusion].
    Mugishima H; Kamise H; Mimaya J
    Rinsho Ketsueki; 1981 Oct; 22(10):1628-31. PubMed ID: 7334603
    [No Abstract]   [Full Text] [Related]  

  • 74. Artificial liver: a baby delivered prematurely.
    Berk PD
    Gastroenterology; 1978 Apr; 74(4):789-91. PubMed ID: 631514
    [No Abstract]   [Full Text] [Related]  

  • 75. Use of sorbent columns and haemofiltration in fulminant hepatic failure.
    Hughes RD; Williams R
    Blood Purif; 1993; 11(3):163-9. PubMed ID: 8280438
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Membranes in artificial organs: a state-of-the-problem discussion.
    Sparks RE; Dorson WJ; Richardson PD; Colton CK; Malchesky P
    Trans Am Soc Artif Intern Organs; 1983; 29():760-3. PubMed ID: 6673322
    [No Abstract]   [Full Text] [Related]  

  • 77. New horizon in dialysis depuration: Characterization of a polysulfone membrane able to break the 'albumin wall'.
    Cuoghi A; Caiazzo M; Monari E; Bellei E; Bergamini S; Sereni L; Aucella F; Loschiavo C; Atti M; Tomasi A
    J Biomater Appl; 2015 May; 29(10):1363-71. PubMed ID: 25542733
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Biochemical monitoring of encephalopathy in liver failure.
    Lancet; 1980 Oct; 2(8198):783-4. PubMed ID: 6107458
    [No Abstract]   [Full Text] [Related]  

  • 79. Reduction of elevated cytokine levels in acute/acute-on-chronic liver failure using super-large pore albumin dialysis treatment: an in vitro study.
    Dominik A; Stange J; Pfensig C; Borufka L; Weiss-Reining H; Eggert M
    Ther Apher Dial; 2014 Aug; 18(4):347-52. PubMed ID: 24215331
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The next step from high-flux dialysis: application of sorbent technology.
    Winchester JF; Ronco C; Brady JA; Cowgill LD; Salsberg J; Yousha E; Choquette M; Albright R; Clemmer J; Davankov V; Tsyurupa M; Pavlova L; Pavlov M; Cohen G; Hörl W; Gotch F; Levin NW
    Blood Purif; 2002; 20(1):81-6. PubMed ID: 11803163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.